About EUSA Pharma
EUSA Pharma is a Healthcare company based in Hemel Hempstead (United Kingdom) founded in 2006, and was acquired by Recordati in December 2021. Developer and commercializer of pharmaceutical medicines. EUSA Pharma has completed 2 acquisitions, including Cytogen and OPi Group. Its focus areas include Traditional Pharmaceuticals, Generics and Diversified. Its legal entity is Recordati Industria Chimica e Farmaceutica S.p.A.
Company details
EUSA Pharma was founded in 2006 and is headquartered in Hemel Hempstead, United Kingdom. Operations in the pharmaceutical sector involve research and development, manufacturing, and distribution of medications targeting both common and rare diseases. A portfolio of products spans multiple therapeutic areas. Responsible business practices are upheld throughout all activities.
- Headquarters Hemel Hempstead, United Kingdom
- Stage Acquired
- SectorsHealthcare
- Website eusapharma.com
- Social LinkedIn
- Acquired by Recordati (Dec 2021)
- Legal Name Recordati Industria Chimica E Farmaceutica S.P.A
- InvestorsJazz Pharmaceuticals
& 1 more
- Investments & AcquisitionsCytogen
& 1 more
- Acquired by
Investors in EUSA Pharma
EUSA Pharma has secured backing from 2 investors, including institutional investors. Prominent investors backing the company include Jazz Pharmaceuticals and Recordati.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
Intergrated pharma focused on development, manufacturing and marketing of drugs | 1926 | recordati.com | Milan, Italy | |
Novel biopharmaceutical medicines are developed for unmet medical needs. | 2003 | jazzpharma.com | Dublin, Ireland |
Investor details for EUSA Pharma
The complete investor list, round-by-round participation and investor portfolios require an active premium plan.
- Complete investor list
- Round participation
- Investor portfolios
- Co-investor network
Verified entity values are shown only after access is granted.
People of EUSA Pharma
13 people are tracked at EUSA Pharma (6 in leadership, 7 in team).
| Name | Role | Group |
|---|---|---|
Eric Hurel | Head Of HR Us, Europe And Emerging Markets | Leadership |
Ignacio Alvarez | Global Medical Director | Leadership |
Alvina To | Associate Director Business Development | Leadership |
Janet Otts-Watson | National Sales Director | Leadership |
Gaël le Rouzo | Global Market Access And Pricing Director | Leadership |
Rick Baker | Regional Business Director | Leadership |
Nathalie Magee | Senior Financial Manager Statutory Reporting | Team |
Karan Kanhai | Global Medical Lead | Team |
Aurélien Millet | Medical Affairs Manager Rare Disease | Team |
Shirley Delung | Key Account Manager-rare Disease Oncology-hematology | Team |
Martin Herold | Medical Science Liasion - Oncology & Rare Disease | Team |
Amy Glover Rn | Key Account Manager | Team |
Lesley Watson | Supply Chain Analyst | Team |
Complete people profiles for EUSA Pharma
Full employee and board profiles, team structure, tenure and professional contact details require an active premium plan.
- Full employee list
- Team structure
- Board tenure
- Professional contacts
Verified entity values are shown only after access is granted.
Investments & Acquisitions by EUSA Pharma
EUSA Pharma has strategically engaged in corporate development activities, having acquired 2 companies. Notable acquisitions include Cytogen and OPi Group.
| Company Name | Description | Domain | Location | Founded | Acquired | Amount |
|---|---|---|---|---|---|---|
Biotechnology innovations are researched, developed, produced, and marketed. | cytogen.com | Princeton, United States | 1980 | May 2008 | $22.6M | |
Enzymatic therapeutics for rare and severe diseases are developed. | orphan-opi.com | Dardilly, France | 1999 | Mar 2007 | •••• |
Complete acquisition details for EUSA Pharma
Acquired stakes, deal sources and the complete acquisition history require an active premium plan.
- Acquired stakes
- Deal sources
- Complete history
- Exports
Verified entity values are shown only after access is granted.
Timeline of EUSA Pharma
5 dated milestones of EUSA Pharma across 15 years, from founding to its latest funding, stage changes and deals.
- Founded EUSA Pharma is founded.
- Acquisition Acquires OPi Group.
- Acquisition Acquires Cytogen.
- Exit Acquired by Jazz Pharmaceuticals.
- Exit Acquired by Recordati.
Web traffic of EUSA Pharma
Websites that share an audience with EUSA Pharma (eusapharma.com).
Websites whose visitors overlap most with EUSA Pharma. Affinity shows how closely the audiences match.
| Website | Domain | Audience affinity | Monthly visits | Global rank | Profile |
|---|---|---|---|---|---|
| novartis.com | 100% | 948.8K | #58,822 | View details | |
| pharmamar.com | 100% | 13.4K | View details | ||
| eisai.com | 88% | 74.5K | #534,857 | View details | |
| ncgs.com | 88% | View details | |||
| btgplc.com | 88% | View details | |||
| •••••••••• | ••••••.com | ••% | •.•M | #••••• | – |
| •••••••••• | ••••••.com | ••% | •.•M | #••••• | – |
| •••••••••• | ••••••.com | ••% | •.•M | #••••• | – |
All 9 similar websites and full traffic analytics for EUSA Pharma
The complete similar-websites list, audience overlap and engagement analytics require an active premium plan.
- 9 similar websites
- Audience overlap
- Engagement analytics
- Traffic by brand
Verified entity values are shown only after access is granted.
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Frequently Asked Questions about EUSA Pharma
EUSA Pharma was founded in 2006.
EUSA Pharma is headquartered in Hemel Hempstead, United Kingdom.
EUSA Pharma was founded in 2006 and is headquartered in Hemel Hempstead, United Kingdom. Operations in the pharmaceutical sector involve research and development, manufacturing, and distribution of medications targeting both common and rare diseases. A portfolio of products spans multiple therapeutic areas. Responsible business practices are upheld throughout all activities.
EUSA Pharma has 2 investors. Key investors include Jazz Pharmaceuticals, and Recordati.
EUSA Pharma operates through Recordati Industria Chimica E Farmaceutica S.P.A.
Yes. EUSA Pharma was acquired by Recordati in December 2021.